JPRN-UMIN000000899已完成未知
Improvement effects of pioglitazone on endothelial function after sirolimus-eluting stent (Cypher stent) implantation: a randomized, open rabelled, prospective study. - Improvement effects of pioglitazone on endothelial function after Cypher stent implantation: a randomized study.
Chiba University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2007年11月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Acute myocardial infarction, heart failure, severe hepatic or renal dysfunction, already to take pioglitazone, pregnancy and in-stent restenotic lesion.
研究者
相似试验
已完成
4 期
Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus ErythematosusSystemic Lupus ErythematosusNCT01322308National Heart Institute, Mexico30
已完成
4 期
Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.Diabetes MellitusNCT00770835Takeda39
已完成
不适用
Effect of alogliptin/pioglitazone on endothelial function and Visceral fat of Type 2DiabetesType2 diabetesJPRN-UMIN000023463Dokkyo medical university hospital30
进行中（未招募）
1 期
The effect of Pioglitazone on vascular and ventricular function in people with type 2 diabetes PICCOLA - PICCOLADiabetesEUCTR2007-001222-27-GBImperial College London24
进行中（未招募）
不适用
EffectS of PiogLitazone on ENDOthelial progenitoR cells in type 2 diabetic patients with vascular complications - The SPLENDOR Study - SPLENDORType 2 diabetesMedDRA version: 9.1Level: HLTClassification code 10012654Term: Diabetic complications cardiovascularEUCTR2007-003077-44-ITTAKEDA